169 related articles for article (PubMed ID: 37934158)
21. Idiopathic basal ganglia calcification-associated PDGFRB mutations impair the receptor signalling.
Arts FA; Velghe AI; Stevens M; Renauld JC; Essaghir A; Demoulin JB
J Cell Mol Med; 2015 Jan; 19(1):239-48. PubMed ID: 25292412
[TBL] [Abstract][Full Text] [Related]
22. Potentiation of platelet-derived growth factor receptor-β signaling mediated by integrin-associated MFG-E8.
Motegi S; Garfield S; Feng X; Sárdy M; Udey MC
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2653-64. PubMed ID: 21868707
[TBL] [Abstract][Full Text] [Related]
23. Functional Characterization of Germline Mutations in PDGFB and PDGFRB in Primary Familial Brain Calcification.
Vanlandewijck M; Lebouvier T; Andaloussi Mäe M; Nahar K; Hornemann S; Kenkel D; Cunha SI; Lennartsson J; Boss A; Heldin CH; Keller A; Betsholtz C
PLoS One; 2015; 10(11):e0143407. PubMed ID: 26599395
[TBL] [Abstract][Full Text] [Related]
24. Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes.
Ruan J; Luo M; Wang C; Fan L; Yang SN; Cardenas M; Geng H; Leonard JP; Melnick A; Cerchietti L; Hajjar KA
Blood; 2013 Jun; 121(26):5192-202. PubMed ID: 23632889
[TBL] [Abstract][Full Text] [Related]
25. PKG II inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cells.
Wang Y; Appiah-Kubi K; Lan T; Wu M; Pang J; Qian H; Tao Y; Jiang L; Wu Y; Chen Y
Cell Biol Int; 2018 Sep; 42(10):1358-1369. PubMed ID: 29935031
[TBL] [Abstract][Full Text] [Related]
26. The E3 Ubiquitin Ligase TRIM21 Regulates Basal Levels of PDGFRβ.
Sarri N; Papadopoulos N; Lennartsson J; Heldin CH
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175489
[TBL] [Abstract][Full Text] [Related]
27. Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor beta (PDGFR beta).
Takayama Y; May P; Anderson RG; Herz J
J Biol Chem; 2005 May; 280(18):18504-10. PubMed ID: 15753096
[TBL] [Abstract][Full Text] [Related]
28. Platelet-derived growth factor receptor β activation and regulation in murine myelofibrosis.
Kramer F; Dernedde J; Mezheyeuski A; Tauber R; Micke P; Kappert K
Haematologica; 2020 Aug; 105(8):2083-2094. PubMed ID: 31672904
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the platelet-derived growth factor receptor-beta by G protein-coupled receptor kinase-5 in vascular smooth muscle cells involves the phosphatase Shp2.
Wu JH; Goswami R; Cai X; Exum ST; Huang X; Zhang L; Brian L; Premont RT; Peppel K; Freedman NJ
J Biol Chem; 2006 Dec; 281(49):37758-72. PubMed ID: 17018529
[TBL] [Abstract][Full Text] [Related]
30. Reciprocal regulation of the platelet-derived growth factor receptor-beta and G protein-coupled receptor kinase 5 by cross-phosphorylation: effects on catalysis.
Cai X; Wu JH; Exum ST; Oppermann M; Premont RT; Shenoy SK; Freedman NJ
Mol Pharmacol; 2009 Mar; 75(3):626-36. PubMed ID: 19092051
[TBL] [Abstract][Full Text] [Related]
31. LRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activation.
Zhou L; Takayama Y; Boucher P; Tallquist MD; Herz J
PLoS One; 2009 Sep; 4(9):e6922. PubMed ID: 19742316
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
33. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).
Heinrich MC; McArthur GA; Demetri GD; Joensuu H; Bono P; Herrmann R; Hirte H; Cresta S; Koslin DB; Corless CL; Dirnhofer S; van Oosterom AT; Nikolova Z; Dimitrijevic S; Fletcher JA
J Clin Oncol; 2006 Mar; 24(7):1195-203. PubMed ID: 16505440
[TBL] [Abstract][Full Text] [Related]
34. Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins.
Yokote K; Hellman U; Ekman S; Saito Y; Rönnstrand L; Saito Y; Heldin CH; Mori S
Oncogene; 1998 Mar; 16(10):1229-39. PubMed ID: 9546424
[TBL] [Abstract][Full Text] [Related]
35. Reciprocal Interaction Between Pericytes and Macrophage in Poststroke Tissue Repair and Functional Recovery.
Shibahara T; Ago T; Tachibana M; Nakamura K; Yamanaka K; Kuroda J; Wakisaka Y; Kitazono T
Stroke; 2020 Oct; 51(10):3095-3106. PubMed ID: 32933419
[TBL] [Abstract][Full Text] [Related]
36. The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer.
Forte L; Turdo F; Ghirelli C; Aiello P; Casalini P; Iorio MV; D'Ippolito E; Gasparini P; Agresti R; Belmonte B; Sozzi G; Sfondrini L; Tagliabue E; Campiglio M; Bianchi F
BMC Cancer; 2018 May; 18(1):586. PubMed ID: 29792166
[TBL] [Abstract][Full Text] [Related]
37. Clinical and molecular response to dasatinib in an adult patient with Penttinen syndrome.
Iznardo H; Bredrup C; Bernal S; Gladkauskas T; Mascaró JM; Roé E; Baselga E
Am J Med Genet A; 2022 Apr; 188(4):1233-1238. PubMed ID: 34894066
[TBL] [Abstract][Full Text] [Related]
38. A Point Mutation in PDGFRB Causes Autosomal-Dominant Penttinen Syndrome.
Johnston JJ; Sanchez-Contreras MY; Keppler-Noreuil KM; Sapp J; Crenshaw M; Finch NA; Cormier-Daire V; Rademakers R; Sybert VP; Biesecker LG
Am J Hum Genet; 2015 Sep; 97(3):465-74. PubMed ID: 26279204
[TBL] [Abstract][Full Text] [Related]
39. Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFRβ signaling in cancer-associated fibroblasts.
Chen W; Yang X; Sun J; Chen Y; Zhao W; He C; An H; Pang J; Xu W; Wen B; Sun H; He S
J Ethnopharmacol; 2023 Jan; 301():115825. PubMed ID: 36240978
[TBL] [Abstract][Full Text] [Related]
40. Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma.
Tamborini E; Bonadiman L; Greco A; Gronchi A; Riva C; Bertulli R; Casali PG; Pierotti MA; Pilotti S
Clin Cancer Res; 2004 Feb; 10(3):938-43. PubMed ID: 14871970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
